Related Experiment Video
Updated: Jul 19, 2025

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
Tyrosinase Inhibitors: A Perspective
Mason A Baber1, Cole M Crist2, Noah L Devolve3
1Department of Medicinal Chemistry, University of Michigan, Ann Arbor, MI 48209, USA.
Researchers are developing new tyrosinase inhibitors for cosmetic and agricultural uses. This review covers key developments in tyrosinase inhibitor research from 2003-2023, focusing on successful molecules and strategies.
Area of Science:
- Biochemistry
- Enzymology
- Medicinal Chemistry
Background:
- Tyrosinase is crucial for melanin biosynthesis across life.
- Existing tyrosinase inhibitors face efficacy and toxicity issues, limiting market use.
- Continued research seeks novel inhibitors for cosmetic and agricultural applications.
Purpose of the Study:
- To review research on tyrosinase inhibitors from 2003-2023.
- To highlight significant molecules and advancements in the field.
- To provide a perspective on the evolution of tyrosinase inhibitor development.
Main Methods:
- Literature review of scientific publications from 2003-2023.
- Analysis of research trends and key findings in tyrosinase inhibition.
- Identification and discussion of exemplar tyrosinase inhibitor molecules.
Main Results:
- Significant progress in identifying diverse classes of tyrosinase inhibitors.
- Development of molecules with improved efficacy and safety profiles.
- Insights into structure-activity relationships for effective tyrosinase inhibition.
Conclusions:
- The field of tyrosinase inhibitors has advanced considerably over the past two decades.
- Ongoing research continues to yield promising candidates for various applications.
- Future directions include optimizing existing inhibitors and exploring novel mechanisms.
Related Concept Videos
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...

